Amgen Inc. (NASDAQ: AMGN) is a large market cap stock with a market cap of 128973.84. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 18.12, a forward P/E of 13.99 and EPS of 9.45. At a stock price of 171.65 (0.22%) it has a dividend yield of 2.34%.
EPS growth for the last five years have been 13.60%, more recently this last year it has grown by 35.20%. The next year growth is going to be about 9.59% and more long-term 8.48% after five years. EPS growth quarter over quarter is 18.50%. Sales growth for the past five years have been 7.60% and sales growth quarter over quarter is 9.80%.
For performance, Amgen Inc. the past week has seen a gain of 4.32%. For the last month performance for Amgen Inc. is 15.40%. While the last quarter is 7.38% and half year, 17.02%. Finally for the year, performance is 2.23%.
The 52-week high for Amgen Inc., is at -3.37%, and for the 52-week low it comes to a value of 34.42%. The 20-day simple moving average is 9.57% and 11.69% for the 200-day simple moving average.
Volatility for the week is at 1.98%, and for the month it is 1.63%. Amgen Inc., has a target price of 184.12.
In terms of debt, long term debt/equity is 1.12, and for total debt/equity Amgen Inc. has 1.2. The gross margin is 81.00%, while operating margin is 39.90%, the profit margin is 32.60%. The current ratio is 5 and the quick ratio is 4.7.
Insider ownership is at 0.20%, with instituitional ownership at 81.60%. Amgen Inc. has a payout ratio of 35.30%. With the total shares outstanding coming to 753. The shares float is 750.35, with the float short at 1.04%, with short ratio coming to 2.7.
In terms of returns, the return on assets see Amgen Inc., get 10.00%, with its returns on investment at 12.50%. Return on equity is 25.70%. So will the investors see the target price of 184.12, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.